The changes (%) in the relative PARP1/ACTB and PARP2/ACTB mRNA cellular content (± Standard Error, SE) as compared to the corresponding control values (untreated cells) induced by the treatment of UWB1.289, UWB1.289 + BRCA1, SKOV-3 and OVCAR-3 human ovarian cancer cells with ASA-A, ASA-B, ASA-C and POPA at 20 and 40 μΜ concentrations for 72 h, as demonstrated by the quantitative PCR analysis, are presented in Figure 5, Figure 7, respectively. This evidence concerns the gene BRCA1 and ovarian carcinoma.